Skip to content

Clinical trials

Phase 2 Lupus Nephritis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Nephritis Phase: Phase 2 Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20171
20182
20191
20201
20222
20234
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Terminated4
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Alexion Pharmaceuticals, Inc.1
Aurinia Pharmaceuticals Inc.1
BeiGene1
Bristol-Myers Squibb1
CytoMed & Beike1
Haisco Pharmaceutical Group Co., Ltd.1
Jiangsu Renocell Biotech Company1
Kezar Life Sciences, Inc.1
Lingyun Sun1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Nephritis17
Lupus Erythematosus, Systemic3
Nephritis3
Glomerulonephritis1
Glomerulonephritis, IGA1
Glomerulonephritis, Membranous1
Kidney Diseases1
Proteinuria1
Urologic Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.